Weekly Insider Transactions Chart

ViewPress Alt plus down arrow to view menu options.Filter by TransactionFilter by Position

buy

sell

acquisition (non open market)

disposition (non open market)

private buy

private sell

automatic buy

automatic sell

option execute

show THRX price

This chart summarizes weekly insider transactions for THRX for the last 12 months. Each bar in the chart represents activity for that week. Mouseover each for details, or view this data in table format in the Weekly Insider Transactions table below.

Recent Recap

Recent recap provides a one and eight week measurement of insider sentiment by tracking the ratio of insider sales to insider purchases. When insiders buy or sell their company's stock it is conjectured that they state their opinion of the company's future.

Insider Sentiment is calculated by adding all insider direct open market sells and buys (excluding option-related transactions) that have occurred in the time period. If the buys outweigh the sells it is a POSITIVE sentiment. If the sells outweigh the buys it is NEGATIVE. If the buys and sells are approximately equal or there have been no transactions the Insider Sentiment is considered NEUTRAL.

Sell/Buy Ratio is calculated by dividing the total number of insider sales into the total number of buys filed with the SEC each week. The eight-week ratio is a moving average of the weekly ratio. A ratio of less than 2.0 is considered bullish and over 2.5 is bearish. The trend of the sell/buy ratio can also be important. A value below 2.0 with a ratio that has been declining over the previous eight weeks is considered more bullish.

WEEKLY TRANSACTION BREAKDOWN

03/02/2015
–
03/09/2015

Transaction

Shares

Buy (1)

92,674

WEEKLY TRANSACTION BREAKDOWN

02/20/2015
–
02/27/2015

Transaction

Shares

Disposition (Non Open Market) (1)

6,789

WEEKLY TRANSACTION BREAKDOWN

01/07/2015
–
01/14/2015

Transaction

Shares

Acquisition (Non Open Market) (4)

355,886

WEEKLY TRANSACTION BREAKDOWN

12/22/2014
–
12/29/2014

Transaction

Shares

Acquisition (Non Open Market) (4)

22,750

WEEKLY TRANSACTION BREAKDOWN

11/04/2014
–
11/11/2014

Transaction

Shares

Buy (1)

832,456

WEEKLY TRANSACTION BREAKDOWN

10/30/2014
–
11/06/2014

Transaction

Shares

Initial (1)

--

Acquisition (Non Open Market) (1)

23,133

WEEKLY TRANSACTION BREAKDOWN

10/16/2014
–
10/23/2014

Transaction

Shares

Acquisition (Non Open Market) (1)

102,471

WEEKLY TRANSACTION BREAKDOWN

10/09/2014
–
10/16/2014

Transaction

Shares

Initial (1)

--

WEEKLY TRANSACTION BREAKDOWN

08/20/2014
–
08/27/2014

Transaction

Shares

Disposition (Non Open Market) (4)

13,044

WEEKLY TRANSACTION BREAKDOWN

08/11/2014
–
08/18/2014

Transaction

Shares

Buy (1)

172,651

Sell (3)

81,580

Acquisition (Non Open Market) (1)

43,905

Disposition (Non Open Market) (1)

96,250

Option Execute (2)

108,108

WEEKLY TRANSACTION BREAKDOWN

07/01/2014
–
07/08/2014

Transaction

Shares

Initial (1)

--

WEEKLY TRANSACTION BREAKDOWN

06/16/2014
–
06/23/2014

Transaction

Shares

Acquisition (Non Open Market) (7)

205,718

WEEKLY TRANSACTION BREAKDOWN

06/02/2014
–
06/09/2014

Transaction

Shares

Initial (4)

-131,072

Acquisition (Non Open Market) (9)

550,410

WEEKLY TRANSACTION BREAKDOWN

05/22/2014
–
05/29/2014

Transaction

Shares

Acquisition (Non Open Market) (7)

42,000

WEEKLY TRANSACTION BREAKDOWN

05/09/2014
–
05/16/2014

Transaction

Shares

Buy (1)

317,770

Disposition (Non Open Market) (6)

150,795

WEEKLY TRANSACTION BREAKDOWN

04/27/2014
–
05/04/2014

Transaction

Shares

Acquisition (Non Open Market) (6)

258,750

WEEKLY TRANSACTION BREAKDOWN

04/17/2014
–
04/24/2014

Transaction

Shares

Option Execute (1)

25,806

WEEKLY TRANSACTION BREAKDOWN

04/07/2014
–
04/14/2014

Transaction

Shares

Option Execute (1)

25,806

WEEKLY TRANSACTION BREAKDOWN

03/31/2014
–
04/07/2014

Transaction

Shares

Option Execute (1)

25,806

WEEKLY TRANSACTION BREAKDOWN

03/21/2014
–
03/28/2014

Transaction

Shares

Option Execute (1)

25,806

WEEKLY TRANSACTION BREAKDOWN

03/13/2014
–
03/20/2014

Transaction

Shares

Disposition (Non Open Market) (1)

1,200

WEEKLY TRANSACTION BREAKDOWN

03/06/2014
–
03/13/2014

Transaction

Shares

Option Execute (2)

67,959

GLAXOSMITHKLINE, PLC — Beneficial Owner (10% or more)

5 Most Recent Transactions (Last 2 Years)

Date

Transaction

Shares

03/02/15

Buy

92,674

11/04/14

Buy

832,456

08/11/14

Buy

172,651

05/09/14

Buy

317,770

02/11/14

Private Buy

342,229

AGUIAR, MICHAEL W. — Chief Executive Officer

5 Most Recent Transactions (Last 2 Years)

Date

Transaction

Shares

02/20/15

Disposition (Non Open Market)

6,789

01/07/15

Acquisition (Non Open Market)

176,056

08/15/14

Acquisition (Non Open Market)

43,905

06/16/14

Acquisition (Non Open Market)

28,365

06/02/14

Acquisition (Non Open Market)

71,000

AGUIAR, MICHAEL W. — Chief Executive Officer

5 Most Recent Transactions (Last 2 Years)

Date

Transaction

Shares

02/20/15

Disposition (Non Open Market)

6,789

01/07/15

Acquisition (Non Open Market)

176,056

08/15/14

Acquisition (Non Open Market)

43,905

06/16/14

Acquisition (Non Open Market)

28,365

06/02/14

Acquisition (Non Open Market)

71,000

ABERCROMBIE, GEORGE B. — Senior Vice President

5 Most Recent Transactions (Last 2 Years)

Date

Transaction

Shares

01/07/15

Acquisition (Non Open Market)

71,429

06/19/14

Acquisition (Non Open Market)

10,000

WITEK, THEODORE L., JR. — Senior Vice President

5 Most Recent Transactions (Last 2 Years)

Date

Transaction

Shares

01/07/15

Acquisition (Non Open Market)

71,429

DESPARBES, ERIC — Chief Financial Officer

5 Most Recent Transactions (Last 2 Years)

Date

Transaction

Shares

01/07/15

Acquisition (Non Open Market)

36,972

10/16/14

Acquisition (Non Open Market)

102,471

FRIEDMAN, CATHY — Director

5 Most Recent Transactions (Last 2 Years)

Date

Transaction

Shares

12/22/14

Acquisition (Non Open Market)

6,500

06/02/14

Acquisition (Non Open Market)

15,170

TYREE, JAMES L. — Director

5 Most Recent Transactions (Last 2 Years)

Date

Transaction

Shares

12/22/14

Acquisition (Non Open Market)

6,500

06/02/14

Acquisition (Non Open Market)

15,170

WALTRIP, WILLIAM H. — Director

5 Most Recent Transactions (Last 2 Years)

Date

Transaction

Shares

12/22/14

Acquisition (Non Open Market)

3,250

05/22/14

Acquisition (Non Open Market)

6,000

03/31/14

Option Execute

25,806

04/24/13

Acquisition (Non Open Market)

6,000

05/15/12

Acquisition (Non Open Market)

6,000

PEPE, PAUL — Director

5 Most Recent Transactions (Last 2 Years)

Date

Transaction

Shares

12/22/14

Acquisition (Non Open Market)

6,500

06/02/14

Acquisition (Non Open Market)

15,170

GLAXOSMITHKLINE, PLC — Beneficial Owner (10% or more)

5 Most Recent Transactions (Last 2 Years)

Date

Transaction

Shares

03/02/15

Buy

92,674

11/04/14

Buy

832,456

08/11/14

Buy

172,651

05/09/14

Buy

317,770

02/11/14

Private Buy

342,229

KEARNEY, TERRENCE C. — Director

5 Most Recent Transactions (Last 2 Years)

Date

Transaction

Shares

10/30/14

Acquisition (Non Open Market)

23,133

KEARNEY, TERRENCE C. — Director

5 Most Recent Transactions (Last 2 Years)

Date

Transaction

Shares

10/30/14

Acquisition (Non Open Market)

23,133

DESPARBES, ERIC — Chief Financial Officer

5 Most Recent Transactions (Last 2 Years)

Date

Transaction

Shares

01/07/15

Acquisition (Non Open Market)

36,972

10/16/14

Acquisition (Non Open Market)

102,471

DESPARBES, ERIC — Chief Financial Officer

5 Most Recent Transactions (Last 2 Years)

Date

Transaction

Shares

01/07/15

Acquisition (Non Open Market)

36,972

10/16/14

Acquisition (Non Open Market)

102,471

LEE, JUNNING — Senior Vice President

5 Most Recent Transactions (Last 2 Years)

Date

Transaction

Shares

08/20/14

Disposition (Non Open Market)

3,261

08/13/14

Option Execute

74,441

08/13/14

Sell

53,424

06/16/14

Acquisition (Non Open Market)

19,855

06/02/14

Acquisition (Non Open Market)

64,700

SHAFER, BRADFORD J. — Secretary

5 Most Recent Transactions (Last 2 Years)

Date

Transaction

Shares

08/20/14

Disposition (Non Open Market)

3,261

08/12/14

Sell

1,048

08/11/14

Option Execute

33,667

08/11/14

Sell

27,108

06/16/14

Acquisition (Non Open Market)

28,365

BLUM, LEONARD M. — Senior Vice President

5 Most Recent Transactions (Last 2 Years)

Date

Transaction

Shares

08/20/14

Disposition (Non Open Market)

3,261

06/16/14

Acquisition (Non Open Market)

28,365

06/02/14

Acquisition (Non Open Market)

71,000

05/09/14

Disposition (Non Open Market)

18,849

04/27/14

Acquisition (Non Open Market)

37,500

MAMMEN, MATHAI — Senior Vice President

5 Most Recent Transactions (Last 2 Years)

Date

Transaction

Shares

08/20/14

Disposition (Non Open Market)

3,261

06/16/14

Acquisition (Non Open Market)

28,365

06/02/14

Acquisition (Non Open Market)

71,000

05/09/14

Disposition (Non Open Market)

22,833

04/27/14

Acquisition (Non Open Market)

37,500

AGUIAR, MICHAEL W. — Chief Executive Officer

5 Most Recent Transactions (Last 2 Years)

Date

Transaction

Shares

02/20/15

Disposition (Non Open Market)

6,789

01/07/15

Acquisition (Non Open Market)

176,056

08/15/14

Acquisition (Non Open Market)

43,905

06/16/14

Acquisition (Non Open Market)

28,365

06/02/14

Acquisition (Non Open Market)

71,000

As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.

Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.